Fusion Pharmaceuticals Funding: $171M Raised, Series B
Fusion Pharmaceuticals is based in Hamilton, Ontario, Canada. It has raised $171M in total funding. Latest round: Series B.
Fusion Pharmaceuticals funding overview
Fusion Pharmaceuticals is based in Hamilton, Ontario, Canada. Fusion Pharmaceuticals has raised $171M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in April 2019. The round record for Fusion Pharmaceuticals runs through 2019; nothing later has been disclosed. Investors on record include Johnson & Johnson Innovation, TPG Biotech, HealthCap, Genesys Capital, FACIT, Seroba and 7 others. 13 distinct backers are named across the disclosed rounds.
Fusion Pharmaceuticals at a glance
Total raised
$171M
Latest round
Series B
Latest round date
April 2019
Headquarters
Hamilton, Ontario, Canada
Notable investors
Johnson & Johnson Innovation, TPG Biotech, HealthCap, Genesys Capital, FACIT, Seroba, OrbiMed, Federated Hermes
Frequently asked about Fusion Pharmaceuticals funding
How much has Fusion Pharmaceuticals raised?
Fusion Pharmaceuticals has raised $171M in total disclosed funding across the rounds on record.
Who has invested in Fusion Pharmaceuticals?
Johnson & Johnson Innovation, TPG Biotech, HealthCap, Genesys Capital, FACIT, Seroba are named among the investors backing Fusion Pharmaceuticals.
What was the latest Fusion Pharmaceuticals funding round?
The most recent disclosed round is a Series B, announced in April 2019.
Where is Fusion Pharmaceuticals based?
Fusion Pharmaceuticals is based in Hamilton, Ontario, Canada.
When did Fusion Pharmaceuticals last raise?
The last disclosed Fusion Pharmaceuticals round closed in April 2019 at Series B.
We update the Fusion Pharmaceuticals record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Hamilton and their backers are listed below.
